Cargando…

Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors

With the introduction of targeted agents primarily applicable to non-small cell lung cancer (NSCLC) of adenocarcinoma histology, there is a heightened unmet need in the squamous cell carcinoma population. Targeting the angiogenic fibroblast growth factor (FGF)/FGF receptor (FGFR) signaling pathway i...

Descripción completa

Detalles Bibliográficos
Autor principal:	Salgia, Ravi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101760/ https://www.ncbi.nlm.nih.gov/pubmed/24711160 http://dx.doi.org/10.1002/cam4.238

Ejemplares similares

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
por: Puri, Neelu, et al.
Publicado: (2008)

Combined Checkpoint Inhibition and Chemotherapy: New Era of 1(st)-Line Treatment for Non-Small-Cell Lung Cancer
por: Wang, Chongkai, et al.
Publicado: (2019)

Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?
por: Villaflor, Victoria M., et al.
Publicado: (2013)

Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression
por: Kanaji, Nobuhiro, et al.
Publicado: (2017)

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
por: Mambetsariev, Isa, et al.
Publicado: (2022)

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer
por: Won, Brian, et al.
Publicado: (2016)

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
por: Tan, Yi-Hung Carol, et al.
Publicado: (2017)

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer
por: Sweis, Randy F, et al.
Publicado: (2016)

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)
por: Salgia, Ravi, et al.
Publicado: (2021)

Role of immunotherapy and co-mutations on KRAS-mutant non-small cell lung cancer survival
por: Amanam, Idoroenyi, et al.
Publicado: (2020)

Dendrobium officinalis inhibited tumor growth in non-small cell lung cancer
por: Pang, Chen, et al.
Publicado: (2020)

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth
por: Xu, Linfeng, et al.
Publicado: (2018)

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
por: Pathak, Ranjan, et al.
Publicado: (2021)

Ubiquitin-specific protease 22 is critical to in vivo angiogenesis, growth and metastasis of non-small cell lung cancer
por: Zhang, Keqiang, et al.
Publicado: (2019)

Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth
por: Takahashi, Akiko, et al.
Publicado: (2015)

Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer
por: Roosan, Moom R., et al.
Publicado: (2021)

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients
por: Poroyko, Valeriy, et al.
Publicado: (2018)

The prognostic significance of fibroblast growth factor receptor 4 in non-small-cell lung cancer
por: Huang, Hong-ping, et al.
Publicado: (2015)

LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer
por: Sattler, Martin, et al.
Publicado: (2023)

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer
por: Kanteti, Rajani, et al.
Publicado: (2014)

Inhibition of HDAC6 Attenuates Tumor Growth of Non-Small Cell Lung Cancer
por: Deskin, Brian, et al.
Publicado: (2019)

TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017)

(−)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer
por: Yang, Xiaohui, et al.
Publicado: (2022)

Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cells
por: Chung, Yuan-Chiang, et al.
Publicado: (2017)

Crosstalk with cancer-associated fibroblasts induces resistance of non-small cell lung cancer cells to epidermal growth factor receptor tyrosine kinase inhibition
por: Choe, Chungyoul, et al.
Publicado: (2015)

Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis
por: Larrieu-Lahargue, Frédéric, et al.
Publicado: (2012)

Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report
por: Roth, Katherine G., et al.
Publicado: (2020)

The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
por: Xu, Maoyi, et al.
Publicado: (2022)

Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion
por: Ma, P C, et al.
Publicado: (2007)

Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer
por: Baroz, Angel R, et al.
Publicado: (2021)

State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017)

Taraxasterol Inhibits Tumor Growth by Inducing Apoptosis and Modulating the Tumor Microenvironment in Non-Small Cell Lung Cancer
por: Lu, Junjie, et al.
Publicado: (2022)

Fibroblast growth factor 11 (FGF11) promotes non-small cell lung cancer (NSCLC) progression by regulating hypoxia signaling pathway
por: Wu, Xiaowei, et al.
Publicado: (2021)

Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer
por: Siegfried, Jill M., et al.
Publicado: (2017)

GDC-0349 inhibits non-small cell lung cancer cell growth
por: Yang, Han, et al.
Publicado: (2020)

Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
por: Shintani, Yasushi, et al.
Publicado: (2023)

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
por: Hsu, Yi-Fan, et al.
Publicado: (2010)

Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer
por: Ge, Guanqun, et al.
Publicado: (2016)

Prevalence and outcome of epidermal growth factor receptor mutations in non-squamous non-small cell lung cancer patients
por: Kota, Rajesh, et al.
Publicado: (2015)

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer
por: Zhang, Liping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1mv8hio9tij5u5t8ra9b2puqgf